Copyright: ©Author(s) 2026.
World J Hepatol. May 27, 2026; 18(5): 116995
Published online May 27, 2026. doi: 10.4254/wjh.v18.i5.116995
Published online May 27, 2026. doi: 10.4254/wjh.v18.i5.116995
Figure 3 Proportion of significant fibrosis (≥ F2) and advanced fibrosis (≥ F3) in all chronic hepatitis C patients with increasing number of risk alleles of IFI16 rs1057028 and AIM2 rs2814770.
A: Significant fibrosis (≥ F2); B: Advanced fibrosis (≥ F3). CHC: Chronic hepatitis C.
- Citation: Arshad I, Majid M, Rauff B, Amar A, Choudhery MS. Genetic polymorphism of IFI16 and AIM2 among Pakistani hepatitis C virus-induced fibrosis patients. World J Hepatol 2026; 18(5): 116995
- URL: https://www.wjgnet.com/1948-5182/full/v18/i5/116995.htm
- DOI: https://dx.doi.org/10.4254/wjh.v18.i5.116995